Osteomyelitis
📧 Sign up to get email alerts when something new happens for Osteomyelitis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-09EMA Authorised: Scintimun (besilesomab) — Telix Innovations
Authorised medicinal product Scintimun (besilesomab) with indications in osteomyelitis and radionuclide imaging.
-
EMA approval · 2025-03-20EMA Authorised: Scintimun (besilesomab) — Telix Innovations
The European Medicines Agency authorised Scintimun (besilesomab) for radionuclide imaging to aid in diagnosing osteomyelitis. Telix Innovati…
-
FDA approval · 2021-11-18FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved vancomycin hydrochloride as a generic drug under an Original Application from Slate Run Pharmaceuticals, LLC.
-
FDA approval · 2021-11-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (Plano Pharmaceuticals Inc.)
The FDA approved a supplemental application for Vancomycin hydrochloride by Plano Pharmaceuticals Inc., approving changes to the approved dr…
-
FDA approval · 2020-09-09FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-06-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the vancomycin hydrochloride original application for Slate Run Pharmaceuticals, enabling a generic version of this antibiotic.
-
FDA approval · 2019-02-15FDA Approved: TYZAVAN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved TYZAVAN (vancomycin) from Hikma Pharmaceuticals USA Inc. under an Original Application (NDA211962). This marks the brand’s offi…
-
FDA approval · 2018-07-10FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved an Original Application for vancomycin hydrochloride from Mylan Institutional LLC, confirming its use for treating serious infe…
-
FDA approval · 2018-04-05FDA Approved: NAFCILLIN — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for Nafcillin submitted by Baxter Healthcare Corporation under NDA 050655.
-
FDA approval · 2018-02-21FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (SAMSON MEDICAL TECHNOLOGIES LLC)
The FDA approved Samson Medical Technologies LLC's supplemental application for vancomycin hydrochloride, a generic antibiotic, under an app…
-
FDA approval · 2016-05-12FDA Approved: CLINDAMYCIN PHOSPHATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the supplemental application for clindamycin phosphate (Padagis Israel Pharmaceuticals Ltd), reflecting approval of the supplem…
-
FDA approval · 2015-05-26FDA Approved: KIT FOR THE PREPARATION OF TECHNETIUM TC 99M MEDRONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for the kit used to prepare technetium-99m medronate for bone imaging, enabling regulatory approval …
-
FDA approval · 2012-04-09FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original ANDA for vancomycin hydrochloride from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., enabling a g…
-
FDA approval · 2011-09-23FDA Approved: TECHNETIUM TC 99M MEDRONATE — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approves a supplemental application for Technetium Tc-99m medronate (Medronate) from Jubilant Radiopharma, updating labeling to reflect …
-
FDA approval · 2011-06-30FDA Approved: NAFCILLIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for Nafcillin sodium (NAFCILLIN SODIUM) as a generic injectable antibiotic from Fresenius Kabi USA, LL…
-
FDA approval · 2011-05-04FDA Approved: CEPHALEXIN — Supplemental Application (AvKARE)
FDA approved a supplemental application for Cephalexin from AvKARE under ANDA 062713, authorizing continued manufacture and marketing of a C…
-
FDA approval · 2011-04-20FDA Approved: NAFCILLIN — Original Application (Athenex Pharmaceutical Division, LLC.)
FDA approves the original application for Nafcillin (nafcillin sodium) as a generic antibiotic from Athenex Pharmaceutical Division, LLC.
-
FDA approval · 2011-02-22FDA Approved: CEPHALEXIN — Supplemental Application (AVKARE)
The FDA approved a supplemental application for Cephalexin from AvKare.
-
FDA approval · 2010-11-29FDA Approved: CEFAZOLIN — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Cefazolin (cefazolin sodium) from Fresenius Kabi USA, LLC, updating an already approved prod…
-
FDA approval · 2010-10-22FDA Approved: TECHNETIUM TC 99M MEDRONATE — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approved a supplemental application for Technetium Tc-99m Medronate (bone imaging agent) submitted by Jubilant DraxImage Inc., dba Jubil…
-
FDA approval · 2009-03-13FDA Approved: METRONIDAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original ANDA from Alembic Pharmaceuticals Limited for a generic metronidazole product.
-
FDA approval · 2008-12-30FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved the original application for vancomycin hydrochloride from Mylan Institutional LLC, marking the approval of a generic injectabl…
-
FDA approval · 2008-09-22FDA Approved: CEPHALEXIN — Supplemental Application (AMELLA PHARMA, LLC)
FDA approved a supplemental application for Cephalexin from Amella Pharma, LLC.
-
FDA approval · 2007-07-25FDA Approved: CEPHALEXIN — Original Application (Chartwell RX, LLC)
FDA approved an Original Application for generic Cephalexin by Chartwell RX, LLC, adding a generic option for this antibiotic.